RecruitingPhase 3NCT03925701
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Sponsor
Sherief Abd-Elsalam
Enrollment
120 participants
Start Date
Apr 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Vildagliptin and a drug called vildagliptin\metformin for people with dm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGVildagliptin
vildagliptin twice daily
DRUGvildagliptin\metformin
vildagliptin\\metformin twice daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03925701